Pharmaceutical Preparations · DE · CIK 1341235
Developing and commercializing medicines for immune-mediated and metabolic diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 19, 2026: 2 insiders bought $105K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 19, 2026 | Douglas RichardDirector | Buy | 70,000 | $1.40 | $98K |
| Mar 18, 2026 | Alfieri MichaelPrincipal Financial Officer | Buy | 5,000 | $1.42 | $7K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.